In autoimmune hepatitis, anti-actin antibody levels correlate with patterns of immune recognition,[4] the pattern of recognition was specific to a small percentage of autoimmune hepatitis type 1 or cryptogenic hepatitis patients.[5]
In gastric cancer anti-actin antibodies were elevated, along with other antibodies in severe disease with poor outcomes.[6]
^Muratori P, Muratori L, Agostinelli D, et al. (2002). "Smooth muscle antibodies and type 1 autoimmune hepatitis". Autoimmunity. 35 (8): 497–500. doi:10.1080/0891693021000054066. PMID12765475.
^Ballot E, Homberg JC, Johanet C (2000). "Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis". J. Hepatol. 33 (2): 208–15. doi:10.1016/S0168-8278(00)80361-X. PMID10952238.
^Konstandoulakis MM, Syrigos KN, Leandros M, Charalabopoulos A, Manouras A, Golematis BC (1998). "Autoantibodies in the serum of patients with gastric cancer: their prognostic importance". Hybridoma. 17 (5): 431–5. doi:10.1089/hyb.1998.17.431. PMID9873988.
^Enright, Helen (Oct 1995). "Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy". British Journal of Haematology. 91 (2): 403–8. doi:10.1111/j.1365-2141.1995.tb05310.x. PMID8547082.